NEW YORK (GenomeWeb News) – Fluidigm reported after the close of the market Monday that its first quarter revenues increased 77 percent year over year, driven by strong instrument sales as well as contributions from a recent acquisition.
Thermo Fisher Scientific and the Department of Systems Biology at the Technical University of Denmark last week announced a collaboration on technology and application development related to research into cellular protein signaling.
DVS Sciences this week introduced its CyTOF 2 Mass Cytometer instrument, an updated version of its original CyTOF mass cytometer. The company also introduced new MaxPar Panel Kits for use with the instrument.
Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.